Soluble E-cadherin: An early marker of severity in acute pancreatitis

HPB Surgery

Volumn , Issue , 2009, Pages

  Charnley, R M ^a   Sewpaul, A ^a   French, J J ^a   Khoo, T K ^a   Kernohan, M ^a   Kirby, J A ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65549157510     PISSN: 08948569     EISSN: 16078462     Source Type: Journal    
DOI: 10.1155/2009/397375     Document Type: Article

References (50)

1. Fitz R., Acute pancreatitis: a consideration of pancreatic haemorrhage, haemorrhagic, suppurative, and gangrenous pancreatitis, and of disseminated fat-necrosis Boston Medical and Surgical Journal 1889 120 181 187, 205-207, 229-235
2. Corfield A. P., Cooper M. J., Williamson R. C., Acute pancreatitis: a lethal disease of increasing incidence Gut 1985 26 7 724 729
3. Neoptolemos J. P., Endoscopic treatment of acute and chronic pancreatitis Italian Journal of Gastroenterology and Hepatology 1998 30 5 556
4. Banerjee A. K., Kaul A., Bache E., Parberry A. C., Doran J., Nicholson M. L., An audit of fatal acute pancreatitis Postgraduate Medical Journal 1995 71 838 472 475
5. Imrie C. W., McKay C. J., The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis Bailliere's Best Practice in Clinical Gastroenterology 1999 13 2 357 364
6. Dervenis C., Johnson C. D., Bassi C., Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference International Journal of Pancreatology 1999 25 3 195 210
7. Uhl W., Warshaw A., Imrie C. W., IAP guidelines for the surgical management of acute pancreatitis Pancreatology 2002 2 6 565 573
8. Johnson C. D., Charnley R., Rowlands B., UK guidelines for the management of acute pancreatitis Gut 2005 54 supplement 3 iii1 iii9
9. Werner J., Feuerbach S., Uhl W., Bchler M. W., Management of acute pancreatitis: from surgery to interventional intensive care Gut 2005 54 3 426 436
10. Johnson C. D., Kingsnorth A. N., Imrie C. W., Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis Gut 2001 48 1 62 69
11. Uhl W., Bchler M., Malfertheiner P., Beger H. G., Adler G., Gaus W., A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis Gut 1999 45 1 97 104
12. Imrie C. W., Mckay A. J., Neill J. O., Short duration megadosage IV Trasylol in primary acute pancreatitisa double-blind trial Gut 1980 21 5 A457 A458
13. Wilson C., Heath D. I., Imrie C. W., Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems British Journal of Surgery 1990 77 11 1260 1264
14. Ranson J. H., Rifkind K. M., Roses D. F., Fink S. D., Eng K., Localio S. A., Objective early identification of severe acute pancreatitis American Journal of Gastroenterology 1974 61 6 443 451
15. Blamey S. L., Imrie C. W., O'Neill J., Gilmour W. H., Carter D. C., Prognostic factors in acute pancreatitis Gut 1984 25 12 1340 1346
16. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E., APACHE II: a severity of disease classification system Critical Care Medicine 1985 13 10 818 829
17. Balthazar E. J., Acute pancreatitis: assessment of severity with clinical and CT evaluation Radiology 2002 223 3 603 613
18. Neoptolemos J. P., Kemppainen E. A., Mayer J. M., Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study The Lancet 2000 355 9219 1955 1960
19. Swaroop V. S., Chari S. T., Clain J. E., Severe acute pancreatitis Journal of the American Medical Association 2004 291 23 2865 2868
20. Johnson C. D., Lempinen M., Imrie C. W., Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis British Journal of Surgery 2004 91 8 1027 1033
21. Sez J., Martnez J., Trigo C., Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis World Journal of Gastroenterology 2005 11 46 7261 7265
22. Inagaki T., Hoshino M., Hayakawa T., Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis Pancreas 1997 14 1 1 8
23. Bidarkundi G. K., Wig J. D., Bhatnagar A., Majumdar S., Clinical relevance of intracellular cytokines IL-6 and IL-12 in acute pancreatitis, and correlation with APACHE III score British Journal of Biomedical Science 2002 59 2 85 89
24. Rau B. M., Kemppainen E. A., Gumbs A. A., Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study Annals of Surgery 2007 245 5 745 754
25. Kylnp-Bck M.-L., Takala A., Kemppainen E. A., Puolakkainen P., Haapiainen R., Repo H., Procalcitonin strip test in the early detection of severe acute pancreatitis British Journal of Surgery 2001 88 2 222 227
26. Ikei S., Ogawa M., Yamaguchi Y., Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis Journal of Gastroenterology and Hepatology 1998 13 12 1274 1283
27. Rau B. M., Steinbach G., Baumgart K., Gansauge F., Grnert A., Beger H. G., Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant Critical Care Medicine 2000 28 3 736 742
28. Wheelock M. J., Buck C. A., Bechtol K. B., Damsky C. H., Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion Journal of cellular biochemistry 1987 34 3 187 202
29. Takeichi M., The cadherins: cell-cell adhesion molecules controlling animal morphogenesis Development 1988 102 4 639 655
30. No V., Fingleton B., Jacobs K., Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 Journal of Cell Science 2001 114 1 111 118
31. Symowicz J., Adley B. P., Gleason K. J., Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells Cancer Research 2007 67 5 2030 2039
32. Nawrocki-Raby B., Gilles C., Polette M., Upregulation of MMPS by soluble E-cadherin in human lung tumor cells International Journal of Cancer 2003 105 6 790 795
33. Ito K., Okamoto I., Araki N., Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of -catenin from cell-cell contacts Oncogene 1999 18 50 7080 7090
34. Davies G., Jiang W. G., Mason M. D., Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion Clinical Cancer Research 2001 7 10 3289 3297
35. Steinhusen U., Weiske J., Badock V., Tauber R., Bommert K., Huber O., Cleavage and Shedding of E-cadherin after Induction of Apoptosis The Journal of Biological Chemistry 2001 276 7 4972 4980
36. Johnson S. K., Ramani V. C., Hennings L., Haun R. S., Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin Cancer 2007 109 9 1811 1820
37. Hayashido Y., Hamana T., Yoshioka Y., Kitano H., Koizumi K., Okamoto T., Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin International Journal of Oncology 2005 27 3 693 698
38. Katayama M., Hirai S., Kamihagi K., Nakagawa K., Yasumoto M., Kato I., Soluble E-cadherin fragments increased in circulation of cancer patients British Journal of Cancer 1994 69 3 580 585
39. Cioffi M., Gazzerro P., Di Finizio B., Serum-soluble E-cadherin fragments in lung cancer Tumori 1999 85 1 32 34
40. Gofuku J., Shiozaki H., Doki Y., Characterization of soluble E-cadherin as a disease marker in gastric cancer patients British Journal of Cancer 1998 78 8 1095 1101
41. Velikova G., Banks R. E., Gearing A., Serum concentrations of soluble adhesion molecules in patients with colorectal cancer British Journal of Cancer 1998 77 11 1857 1863
42. Chan A. O. O., Lam S. K., Chu K. M., Soluble E-cadherin is a valid prognostic marker in gastric carcinoma Gut 2001 48 6 808 811
43. Griffiths T. R. L., Brotherick I., Bishop R. I., Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence British Journal of Cancer 1996 74 4 579 584
44. Sundfeldt K., Ivarsson K., Rask K., Haeger M., Hedin L., Brnnstrm M., Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts Anticancer Research 2001 21 1A 65 70
45. Gadducci A., Ferdeghini M., Cosio S., Preoperative serum E-cadherin assay in patients with ovarian carcinoma Anticancer Research 1999 19 1B 769 772
46. Pittard A. J., Banks R. E., Galley H. F., Webster F. N. R., Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome British Journal of Anaesthesia 1996 76 5 629 631
47. Bradley E. L. III, A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 Archives of Surgery 1993 128 5 586 590
48. Muhs B. E., Patel S., Yee H., Marcus S., Shamamian P., Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis Journal of Surgical Research 2001 101 1 21 28
49. Lerch M. M., Lutz M. P., Weidenbach H., Dissociation and reassembly of adherens junctions during experimental acute pancreatitis Gastroenterology 1997 113 4 1355 1366
50. Norman J., Role of cytokines in the pathogenesis of acute pancreatitis The American Journal of Surgery 1998 175 1 76 83